Adcock Ingram's New CEO To Decentralize South Africa Drug Maker
This article was originally published in PharmAsia News
Executive Summary
Adcock Ingram CEO Kevin Wakeford, newly on the job after Bidvest successfully blocked a CFR Pharmaceuticals takeover earlier this year, said the South Africa drug maker is about to undergo a makeover.